TW200831900A - Cancer screen method - Google Patents

Cancer screen method Download PDF

Info

Publication number: TW200831900A
Authority: TW; Taiwan
Prior art keywords: dna; artificial sequence; target gene; methylation; screening
Prior art date: 2007-01-23

Application number

TW96102422A

Other languages

English (en)

Chinese (zh)

Other versions

TWI329743B (fr

Inventor

Hong-Zheng Lai

Original Assignee

Hong-Zheng Lai

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-01-23

Filing date

2007-01-23

Publication date

2008-08-01

2007-01-23 Application filed by Hong-Zheng Lai filed Critical Hong-Zheng Lai

2007-01-23 Priority to TW96102422A priority Critical patent/TW200831900A/zh

2008-08-01 Publication of TW200831900A publication Critical patent/TW200831900A/zh

2010-09-01 Application granted granted Critical

2010-09-01 Publication of TWI329743B publication Critical patent/TWI329743B/zh

Links

238000000034 method Methods 0.000 title claims abstract description 79
206010028980 Neoplasm Diseases 0.000 title claims abstract description 63
201000011510 cancer Diseases 0.000 title claims abstract description 55
108090000623 proteins and genes Proteins 0.000 claims abstract description 155
238000007069 methylation reaction Methods 0.000 claims abstract description 120
230000011987 methylation Effects 0.000 claims abstract description 118
108020004414 DNA Proteins 0.000 claims abstract description 97
238000012360 testing method Methods 0.000 claims abstract description 84
238000007855 methylation-specific PCR Methods 0.000 claims abstract description 35
101001038339 Homo sapiens LIM homeobox transcription factor 1-alpha Proteins 0.000 claims abstract description 25
101000613575 Homo sapiens Paired box protein Pax-1 Proteins 0.000 claims abstract description 21
102100040290 LIM homeobox transcription factor 1-alpha Human genes 0.000 claims abstract description 20
238000012163 sequencing technique Methods 0.000 claims abstract description 17
102100040851 Paired box protein Pax-1 Human genes 0.000 claims abstract description 16
238000002493 microarray Methods 0.000 claims abstract description 15
101000578254 Homo sapiens Homeobox protein Nkx-6.1 Proteins 0.000 claims abstract description 13
101000652332 Homo sapiens Transcription factor SOX-1 Proteins 0.000 claims abstract description 13
101000988619 Homo sapiens Hepatocyte nuclear factor 6 Proteins 0.000 claims abstract description 11
102100029087 Hepatocyte nuclear factor 6 Human genes 0.000 claims abstract description 9
102100028098 Homeobox protein Nkx-6.1 Human genes 0.000 claims abstract description 8
102100030248 Transcription factor SOX-1 Human genes 0.000 claims abstract description 8
238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 7
238000012216 screening Methods 0.000 claims description 68
206010008342 Cervix carcinoma Diseases 0.000 claims description 64
208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 64
201000010881 cervical cancer Diseases 0.000 claims description 64
210000004027 cell Anatomy 0.000 claims description 45
239000002773 nucleotide Substances 0.000 claims description 31
125000003729 nucleotide group Chemical group 0.000 claims description 31
238000001369 bisulfite sequencing Methods 0.000 claims description 26
230000003902 lesion Effects 0.000 claims description 26
238000004458 analytical method Methods 0.000 claims description 21
LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 19
201000007270 liver cancer Diseases 0.000 claims description 14
208000014018 liver neoplasm Diseases 0.000 claims description 14
238000009595 pap smear Methods 0.000 claims description 14
241000282414 Homo sapiens Species 0.000 claims description 13
238000006177 thiolation reaction Methods 0.000 claims description 9
206010061535 Ovarian neoplasm Diseases 0.000 claims description 8
210000004369 blood Anatomy 0.000 claims description 8
239000008280 blood Substances 0.000 claims description 8
238000001514 detection method Methods 0.000 claims description 8
210000002700 urine Anatomy 0.000 claims description 8
239000002253 acid Substances 0.000 claims description 7
206010003445 Ascites Diseases 0.000 claims description 6
238000012175 pyrosequencing Methods 0.000 claims description 6
206010033128 Ovarian cancer Diseases 0.000 claims description 5
206010036790 Productive cough Diseases 0.000 claims description 5
230000002159 abnormal effect Effects 0.000 claims description 5
210000002919 epithelial cell Anatomy 0.000 claims description 5
238000003752 polymerase chain reaction Methods 0.000 claims description 5
210000003802 sputum Anatomy 0.000 claims description 5
208000024794 sputum Diseases 0.000 claims description 5
210000000941 bile Anatomy 0.000 claims description 4
210000003608 fece Anatomy 0.000 claims description 4
210000004051 gastric juice Anatomy 0.000 claims description 4
-1 NKX64 Proteins 0.000 claims description 3
108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
150000007523 nucleic acids Chemical group 0.000 claims description 2
238000004811 liquid chromatography Methods 0.000 claims 2
241000894007 species Species 0.000 claims 2
CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 claims 1
210000000877 corpus callosum Anatomy 0.000 claims 1
238000004925 denaturation Methods 0.000 claims 1
230000036425 denaturation Effects 0.000 claims 1
238000000197 pyrolysis Methods 0.000 claims 1
238000002255 vaccination Methods 0.000 claims 1
101150084041 WT1 gene Proteins 0.000 abstract description 14
108700020467 WT1 Proteins 0.000 abstract description 12
102000040856 WT1 Human genes 0.000 abstract description 10
238000010998 test method Methods 0.000 abstract description 4
QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 abstract 1
231100000915 pathological change Toxicity 0.000 abstract 1
230000036285 pathological change Effects 0.000 abstract 1
239000000523 sample Substances 0.000 description 46
206010041823 squamous cell carcinoma Diseases 0.000 description 39
210000001519 tissue Anatomy 0.000 description 17
230000035945 sensitivity Effects 0.000 description 15
108091029523 CpG island Proteins 0.000 description 14
241000701806 Human papillomavirus Species 0.000 description 13
208000032124 Squamous Intraepithelial Lesions Diseases 0.000 description 13
FICVQGAXQTVNNK-JHYUDYDFSA-N 4-amino-1-[(2r,4s,5s)-4-hydroxy-5-(hydroxyamino)oxolan-2-yl]pyrimidin-2-one Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](NO)[C@@H](O)C1 FICVQGAXQTVNNK-JHYUDYDFSA-N 0.000 description 7
230000007067 DNA methylation Effects 0.000 description 7
108700025716 Tumor Suppressor Genes Proteins 0.000 description 7
102000044209 Tumor Suppressor Genes Human genes 0.000 description 7
238000003745 diagnosis Methods 0.000 description 7
230000004048 modification Effects 0.000 description 7
238000012986 modification Methods 0.000 description 7
238000011161 development Methods 0.000 description 6
230000014509 gene expression Effects 0.000 description 6
101710106660 Shutoff alkaline exonuclease Proteins 0.000 description 5
230000010632 Transcription Factor Activity Effects 0.000 description 5
210000003679 cervix uteri Anatomy 0.000 description 5
230000002068 genetic effect Effects 0.000 description 5
210000004291 uterus Anatomy 0.000 description 5
208000034254 Squamous cell carcinoma of the cervix uteri Diseases 0.000 description 4
201000006612 cervical squamous cell carcinoma Diseases 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
201000010099 disease Diseases 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
210000003494 hepatocyte Anatomy 0.000 description 4
238000009396 hybridization Methods 0.000 description 4
239000000463 material Substances 0.000 description 4
238000003757 reverse transcription PCR Methods 0.000 description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
241000700605 Viruses Species 0.000 description 3
239000000090 biomarker Substances 0.000 description 3
230000006870 function Effects 0.000 description 3
230000006607 hypermethylation Effects 0.000 description 3
210000004185 liver Anatomy 0.000 description 3
210000005229 liver cell Anatomy 0.000 description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
239000000203 mixture Substances 0.000 description 3
230000002611 ovarian Effects 0.000 description 3
239000013641 positive control Substances 0.000 description 3
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 2
201000009030 Carcinoma Diseases 0.000 description 2
206010008909 Chronic Hepatitis Diseases 0.000 description 2
108091029430 CpG site Proteins 0.000 description 2
229940126190 DNA methyltransferase inhibitor Drugs 0.000 description 2
230000004568 DNA-binding Effects 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
101000578258 Homo sapiens Homeobox protein Nkx-6.2 Proteins 0.000 description 2
108060004795 Methyltransferase Proteins 0.000 description 2
102000016397 Methyltransferase Human genes 0.000 description 2
101150013760 Nkx6-1 gene Proteins 0.000 description 2
101150006446 PAX1 gene Proteins 0.000 description 2
241000282320 Panthera leo Species 0.000 description 2
208000009608 Papillomavirus Infections Diseases 0.000 description 2
102000055027 Protein Methyltransferases Human genes 0.000 description 2
108700040121 Protein Methyltransferases Proteins 0.000 description 2
101150099498 SOX1 gene Proteins 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
208000002495 Uterine Neoplasms Diseases 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
208000019425 cirrhosis of liver Diseases 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
230000034994 death Effects 0.000 description 2
230000037430 deletion Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
239000003968 dna methyltransferase inhibitor Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
230000001973 epigenetic effect Effects 0.000 description 2
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
229960005542 ethidium bromide Drugs 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
239000012634 fragment Substances 0.000 description 2
238000001502 gel electrophoresis Methods 0.000 description 2
230000030279 gene silencing Effects 0.000 description 2
208000014829 head and neck neoplasm Diseases 0.000 description 2
208000006454 hepatitis Diseases 0.000 description 2
239000007788 liquid Substances 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
230000008569 process Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
206010046766 uterine cancer Diseases 0.000 description 2
101150028074 2 gene Proteins 0.000 description 1
101150112497 26 gene Proteins 0.000 description 1
UGQXLWWNSMGEBY-UHFFFAOYSA-N 6-amino-5-sulfanyl-1h-pyrimidin-2-one Chemical compound NC1=NC(=O)NC=C1S UGQXLWWNSMGEBY-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
239000002126 C01EB10 - Adenosine Substances 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
240000006162 Chenopodium quinoa Species 0.000 description 1
108010077544 Chromatin Proteins 0.000 description 1
206010061764 Chromosomal deletion Diseases 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
108010009540 DNA (Cytosine-5-)-Methyltransferase 1 Proteins 0.000 description 1
102100036279 DNA (cytosine-5)-methyltransferase 1 Human genes 0.000 description 1
102100024812 DNA (cytosine-5)-methyltransferase 3A Human genes 0.000 description 1
102100024810 DNA (cytosine-5)-methyltransferase 3B Human genes 0.000 description 1
101710123222 DNA (cytosine-5)-methyltransferase 3B Proteins 0.000 description 1
108010024491 DNA Methyltransferase 3A Proteins 0.000 description 1
230000008836 DNA modification Effects 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
208000009849 Female Genital Neoplasms Diseases 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
238000000729 Fisher's exact test Methods 0.000 description 1
206010064571 Gene mutation Diseases 0.000 description 1
208000031448 Genomic Instability Diseases 0.000 description 1
108010033040 Histones Proteins 0.000 description 1
IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical group OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
102100034343 Integrase Human genes 0.000 description 1
241000155247 Ixos Species 0.000 description 1
101150061841 LMX1A gene Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
229940123379 Methyltransferase inhibitor Drugs 0.000 description 1
102000043276 Oncogene Human genes 0.000 description 1
208000037581 Persistent Infection Diseases 0.000 description 1
ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
238000010240 RT-PCR analysis Methods 0.000 description 1
241000239226 Scorpiones Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
239000007984 Tris EDTA buffer Substances 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
229960005305 adenosine Drugs 0.000 description 1
239000008272 agar Substances 0.000 description 1
230000003321 amplification Effects 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
229910001570 bauxite Inorganic materials 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000027455 binding Effects 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
206010008129 cerebral palsy Diseases 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
210000003483 chromatin Anatomy 0.000 description 1
230000014107 chromosome localization Effects 0.000 description 1
230000007882 cirrhosis Effects 0.000 description 1
239000000571 coke Substances 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000002559 cytogenic effect Effects 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
VUIKXKJIWVOSMF-GHTOIXBYSA-N d(CG)12 Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)O)C1 VUIKXKJIWVOSMF-GHTOIXBYSA-N 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
230000009615 deamination Effects 0.000 description 1
238000006481 deamination reaction Methods 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000017858 demethylation Effects 0.000 description 1
238000010520 demethylation reaction Methods 0.000 description 1
230000003297 denaturating effect Effects 0.000 description 1
238000000280 densification Methods 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
229940014144 folate Drugs 0.000 description 1
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
238000012226 gene silencing method Methods 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
230000036541 health Effects 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
230000006872 improvement Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000003993 interaction Effects 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
238000002372 labelling Methods 0.000 description 1
238000007477 logistic regression Methods 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
208000026037 malignant tumor of neck Diseases 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
239000003697 methyltransferase inhibitor Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
239000008267 milk Substances 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
230000009456 molecular mechanism Effects 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
230000035772 mutation Effects 0.000 description 1
239000013642 negative control Substances 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
108091008819 oncoproteins Proteins 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
239000000376 reactant Substances 0.000 description 1
230000022983 regulation of cell cycle Effects 0.000 description 1
238000007634 remodeling Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
238000005070 sampling Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
235000010265 sodium sulphite Nutrition 0.000 description 1
239000002689 soil Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
208000020077 squamous cell intraepithelial neoplasia Diseases 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
150000003573 thiols Chemical class 0.000 description 1
108091006106 transcriptional activators Proteins 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000005740 tumor formation Effects 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000002699 waste material Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Landscapes

Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

TW96102422A 2007-01-23 2007-01-23 Cancer screen method TW200831900A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
TW96102422A TW200831900A (en)	2007-01-23	2007-01-23	Cancer screen method

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
TW96102422A TW200831900A (en)	2007-01-23	2007-01-23	Cancer screen method

Publications (2)

Publication Number	Publication Date
TW200831900A true TW200831900A (en)	2008-08-01
TWI329743B TWI329743B (fr)	2010-09-01

Family

ID=44818727

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW96102422A TW200831900A (en)	2007-01-23	2007-01-23	Cancer screen method

Country Status (1)

Country	Link
TW (1)	TW200831900A (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2010118559A1 (fr)	2009-04-17	2010-10-21	Lai Hung-Cheng	Procédé pour le dépistage du cancer
US8048634B2 (en)	2009-08-18	2011-11-01	National Defense Medical Center	Cancer screening method
TWI385252B (zh) *	2009-04-16	2013-02-11	Nat Defense Medical Ct	一種癌症篩檢的方法
WO2014032227A1 (fr)	2012-08-28	2014-03-06	日祥医事管理顾问股份有限公司	Composition test pour le dépistage de cancers
WO2014032205A1 (fr)	2012-08-31	2014-03-06	国防医学院	Méthode de dépistage du cancer
TWI513822B (zh) *	2012-08-28	2015-12-21		一種癌症篩檢的檢驗套組

2007
- 2007-01-23 TW TW96102422A patent/TW200831900A/zh unknown

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI385252B (zh) *	2009-04-16	2013-02-11	Nat Defense Medical Ct	一種癌症篩檢的方法
WO2010118559A1 (fr)	2009-04-17	2010-10-21	Lai Hung-Cheng	Procédé pour le dépistage du cancer
US8048634B2 (en)	2009-08-18	2011-11-01	National Defense Medical Center	Cancer screening method
WO2014032227A1 (fr)	2012-08-28	2014-03-06	日祥医事管理顾问股份有限公司	Composition test pour le dépistage de cancers
TWI513822B (zh) *	2012-08-28	2015-12-21		一種癌症篩檢的檢驗套組
WO2014032205A1 (fr)	2012-08-31	2014-03-06	国防医学院	Méthode de dépistage du cancer

Also Published As

Publication number	Publication date
TWI329743B (fr)	2010-09-01

Publication	Publication Date	Title
US11898199B2 (en)	2024-02-13	Detection of colorectal cancer and/or advanced adenomas
CN105586408B (zh)	2021-03-23	一种癌症筛检的方法
US7820386B2 (en)	2010-10-26	Cancer screening method
EP2906716B1 (fr)	2018-01-31	Marqueurs de diagnostic moléculaire hsa-mi124 et fam19a4 pour des cancers invasifs induits par hpv, et leurs lésions de précurseur à haut grade
US12203141B2 (en)	2025-01-21	Methylation classifier for detection of HPV-induced invasive cancers, nonHPV-induced gynaecological and anogenital cancers and their high-grade precursor lesions
EP3341495B1 (fr)	2023-06-07	Zic1 et ghsr, marqueurs de diagnostic moléculaire pour cancers invasifs causés par le vph, cancers gynécologiques et anogénitaux non causés par le vph et leurs lésions précancéreuses de haut grade
KR20150067151A (ko)	2015-06-17	암을 스크리닝하는 방법
HUE034556T2 (en)	2018-02-28	A method for detecting HPV-induced cervical cancer
TWI329743B (fr)	2010-09-01
CN101855348A (zh)	2010-10-06	肝癌相关基因、以及肝癌风险的判定方法
CN109913481B (zh)	2020-04-03	PIK3CA基因g.179224821G＞A突变及其在乳腺癌辅助诊断中的应用
TW201100799A (en)	2011-01-01	Cancer screening method
TW201042260A (en)	2010-12-01	Method for screening cancer
HK1133283B (en)	2017-03-31	A method for screening cancer
Shi	2005	Comprehensive gene environment analysis of the causes of orofacial clefts
JP2004135661A (ja)	2004-05-13	哺乳動物由来の検体の癌化度を評価する方法
JP2005198533A (ja)	2005-07-28	哺乳動物の神経芽細胞腫の予後を判定する方法
HK1209460B (en)	2019-09-13	Hsa-mir124 and fam19a4, molecular diagnostic markers for hpv-induced invasive cancers and their high-grade precursor lesions
CN105803067A (zh)	2016-07-27	miR-1304在转移性肺鳞癌诊治中的应用
JP2004113110A (ja)	2004-04-15	哺乳動物由来の検体の癌化度を評価する方法

TW200831900A - Cancer screen method - Google Patents

Info

Links

Landscapes

Priority Applications (1)

Applications Claiming Priority (1)

Publications (2)

Family

ID=44818727

Family Applications (1)

Country Status (1)

Cited By (6)

Cited By (6)

Also Published As

Similar Documents